Events & Presentations

Date	Documents
August 4, 2020	Corporate Presentation

Archived Investor Events and Presentations

Archived Scientific Presentations

Date	Event Details
Summary Toggle Sep 15, 2020 at 4:40 PM EDT	Cantor Virtual Global Healthcare Conference Listen to Webcast

Date	Documents
Jun 22, 2020	Add Files AACR 2020: Potency-reduced IL12 heterodimeric Fc-fusions exhibit strong anti-tumor activity 1.1 MB
Jun 22, 2020	Add Files AACR 2020: XmAb30819, an XmAb® 2+1 ENPP3 x CD3 bispecific antibody for RCC, demonstrates safety and efficacy in in vivo preclinical studies 792.7 KB
Jun 22, 2020	Add Files AACR 2020: Affinity tuned XmAb®2+1 PSMA x CD3 bispecific antibodies demonstrate selective activity in prostate cancer models 794.3 KB
Jun 22, 2020	Add Files AACR 2020: Affinity tuned XmAb® 2+1 anti-mesothelin x anti-CD3 bispecific antibody induces selective T cell-dependent cellular cytotoxicity of human ovarian cancer cells 810.3 KB
Dec 09, 2019	Add Files ASH 2019: Preliminary Safety and Anti-Tumor Activity of XmAb13676, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with R/R NHL and CLL 520.4 KB
Mar 04, 2019	Add Files Festival of Biologics USA 2019: Tumor selective cytotoxicity by TAA x CD3 bispecifics utilizing a 2:1 mixed-valency format 891.8 KB
Dec 03, 2018	Add Files ASH 2018: Complete Responses in r/r AML Patients on a Weekly Dosing Schedule of XmAb®14045, a CD123 x CD3 T Cell-Engaging Bispecific Antibody: Initial Results of a Phase 1 Study 943.5 KB
Dec 03, 2018	Add Files ASH 2018: Regulatory T cell selective IL-2-Fc fusion proteins for the treatment of autoimmune diseases 8 MB
Nov 09, 2018	Add Files SITC 2018: An IL15/IL15Rα heterodimeric Fc-fusion engineered for reduced potency demonstrates an optimal balance of in vivo activity and exposure 1.3 MB
Nov 09, 2018	Add Files SITC 2018: Simultaneous checkpoint-costimulatory or checkpoint-checkpoint receptor targeting with bispecific antibodies promotes enhanced human T cell activation 699.4 KB
Oct 21, 2018	Add Files ACR 2018: Top-line Results of a Phase 2, Double-blind, Randomized, Placebo-Controlled Study of a Reversible B Cell Inhibitor, XmAb®5871, in Systemic Lupus Erythematosus (SLE) 4 MB
Apr 18, 2018	Add Files AACR 2018: Potency-reduced IL15/IL15Rα heterodimeric Fc-fusions display enhanced in vivo activity through increased exposure 739.8 KB
Apr 16, 2018	Add Files AACR 2018: Simultaneous checkpoint-checkpoint or checkpoint-costimulatory receptor targeting with bispecific antibodies promotes enhanced human T cell activation 703.1 KB
Nov 13, 2017	Add Files SITC 2017: Anti-PD1 x anti-ICOS bispecific antibody XmAb23104 brings together PD1 blockade and ICOS costimulation to promote human T cell activation and proliferation 1.4 MB
Nov 13, 2017	Add Files SITC 2017: Dual Blockade of PD1 and CTLA4 with Bispecific Antibody XmAb20717 Promotes Human T Cell Activation and Proliferation 893.1 KB
Nov 08, 2017	Add Files ACR 2017: Final Results from Phase 2 Study of XmAb 5871 in IgG4-Related Disease 1 MB
Jun 16, 2017	Add Files EULAR 2017: Interim Results of a Phase 2 Study of XmAb®5871, a Reversible B Cell Inhibitor, in IgG4-Related Disease 945 KB
Apr 04, 2017	Add Files AACR 2017: IL 15/IL 15Ra; heterodimeric Fc-fusions with extended half-lives 2.3 MB
Apr 04, 2017	Add Files AACR 2017: Combination of PD1 blockade and T cell costimulation by bispecific antibodies promotes human T cell activation and proliferation 2.7 MB
Apr 04, 2017	Add Files AACR 2017: Anti-SSTR2 x anti-CD3 bispecific antibody induces potent killing of human tumor cells in vitro and in mice, and stimulates target dependent T cell activation in monkeys: A potential immunotherapy for neuroendocrine tumors 2.1 MB
Nov 13, 2016	Add Files Preliminary Data from the Ongoing Open-Label XmAb5871 Phase 2 Pilot Study in IgG4-Related Disease 1.4 MB
Nov 13, 2016	Add Files Preliminary Data from the Ongoing Open-Label XmAb5871 Phase 2 Pilot Study in IgG4-Related Disease 1.4 MB
Nov 09, 2016	Add Files 2016 Society for Immunotherapy of Cancer (SITC) Annual Meeting Poster: Multiple Bispecific Checkpoint Combinations Promote T cell activation 1.1 MB
Nov 09, 2016	Add Files 2016 Society for Immunotherapy of Cancer (SITC) Annual Meeting Poster: Dual Blockade of PD-1 and CTLA-4 with Bispecific Antibodies Promotes Human T cell Activation and Proliferation 1 MB
May 18, 2016	Add Files American Thoracic Society: ATS Conference 2016: A Randomized, Double-Blinded, Placebo-Controlled, Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of XmAb®7195 1 MB
Jun 12, 2015	Add Files European League Against Rheumatism (EULAR) 2015 Annual Meeting Poster: A Phase 1b/2a Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XmAb®5871 in Patients with Rheumatoid Arthritis 1.1 MB
Dec 08, 2014	Add Files American Society of Hematology 2014 Annual Meeting Poster: Anti-CD38 × Anti-CD3 Bispecific Antibodies in Multiple Myeloma Chu, et al, Abstract ID# 4727 3.7 MB
Dec 07, 2014	Add Files American Society of Hematology 2014 Annual Meeting Poster: XmAb Anti-CD20 × Anti-CD3 Bispecific Antibodies in B-cell Lymphomas and Leukemia Chu, et al, Abstract ID# 3111 3.5 MB
Dec 07, 2014	Add Files Xencor American Society of Hematology 2014 Annual Meeting Poster: XmAb Anti-CD123 x Anti-CD3 Bispecific Antibodies in Acute Myleogenous Leukemia Chu, et al, Abstract ID# 2316 4.1 MB

Tools

Events & Presentations

Upcoming Events

Archived Investor Events and Presentations

Archived Scientific Presentations

Cantor Virtual Global Healthcare Conference